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Transcription factors interferon regulatory factor 3
(IRF3) and nuclear factor kB (NFkB) are activated
by external stimuli, including virus infection, to
translocate to the nucleus and bind genomic targets
important for immunity and inflammation. To investi-
gate RNA polymerase II (Pol II) recruitment and
elongation in the human antiviral gene regulatory
network, a comprehensive genome-wide analysis
was conducted during the initial phase of virus
infection. Results reveal extensive integration of
IRF3 and NFkB with Pol II and associated machinery
and implicate partners for antiviral transcription.
Analysis indicates that both de novo polymerase
recruitment and stimulated release of paused poly-
merase work together to control virus-induced
gene activation. In addition to known messenger-
RNA-encoding loci, IRF3 and NFkB stimulate tran-
scription at regions not previously associated with
antiviral transcription, including abundant unanno-
tated loci that encode novel virus-inducible RNAs
(nviRNAs). These nviRNAs are widely induced by
virus infections in diverse cell types and represent
a previously overlooked cellular response to virus
infection.INTRODUCTION
Regulated gene expression is essential for most biological pro-
cesses, from development to disease. Signal-responsive factors
can modulate gene expression through the recruitment of coac-
tivators to the promoter, which initiates a multitude of regulatory
responses that include resolution of inhibitory chromatin config-
urations, modification of transcription regulators, engagement of
Mediator complexes, and recruitment of RNA polymerase II
(Pol II) and its associated machinery, ultimately resulting in
increased rates of Pol II initiation and elongation at the target
locus (Roeder, 1998; Kadonaga, 2004; Malik and Roeder,
2005; Fuda et al., 2009; Taatjes, 2010).CelThe traditional model of inducible transcription initiation facil-
itated primarily through transcription factor-mediated de novo
Pol II recruitment has been supplanted with evidence supporting
prestimulation Pol II occupancy at gene promoters (Adelman
and Lis, 2012). Genome-wide analysis of Pol II distribution has
revealed that many metazoan genes, especially those associ-
ated with signal-responsive pathways, including cell prolifera-
tion, development, stress, or damage responses, display higher
levels of Pol II at their promoters than within the gene body
(Guenther et al., 2007; Muse et al., 2007; Rahl et al., 2010; Cheng
et al., 2012), indicating that the polymerase is paused at the
promoter. Pol II is retained in a paused state in association
with elongation repressors, including 5,6-dichloro-1-b-D-ribo-
furanosylbenzimidazole sensitivity-inducing factor (DSIF) and
negative elongation factor (NELF) (Peterlin and Price, 2006). Acti-
vating stimuli lead to phosphorylation of the Pol II C-terminal
domain (CTD), including phosphorylation of CTD serine 2 (S2)
by the cyclin-dependent kinase, positive transcription elongation
factor b (P-TEFb) (Marshall and Price, 1992, 1995; Wada et al.,
1998; Sims et al., 2004). Pol II phosphorylation patterns and
association with NELF can serve as diagnostic markers for
determining the elongation status of an individual gene.
In addition to revealing novel aspects of Pol II activation,
recent genome-wide RNA profiling experiments have demon-
strated the production of a diversity of RNA transcripts beyond
protein-coding genes (Djebali et al., 2012). RNAs produced
from intergenic and unannotated loci account for a major subset
of the total transcripts made in the human cell, and principles for
long-range gene regulation, facilitated in part by Mediator, are
beginning to be fully appreciated (Kagey et al., 2010; Sanyal
et al., 2012). However, these studies have been carried out at
steady-state rather than coupled with specific gene-activating
stimuli, thereby inadvertently overlooking potential genomic tar-
gets relevant to biological processes.
In higher eukaryotes, transcriptional mechanisms are espe-
cially important for regulating appropriate immune functions,
driving both adaptive and innate responses to pathogens. For
viral pathogens, gene regulatory networks are activated to
create initial barriers for virus replication and to shape subse-
quent innate and adaptive immunity. The inducible transcription
of type I interferon (IFN) genes and other proinflammatory cyto-
kines, as well as primary antiviral effectors, is initiated in
response to virus-induced signal transduction (Taniguchi andl Reports 4, 959–973, September 12, 2013 ª2013 The Authors 959
Takaoka, 2002;Mogensen, 2009; Takeuchi and Akira, 2009), and
secreted IFNs, in turn, can drive transcription of diverse target
genes (de Veer et al., 2001; Stetson and Medzhitov, 2006). The
regulation of cell autonomous antiviral responses has been the
subject of intense investigation, and the virus-activated expres-
sion of the human IFNb gene (Ifnb1) is among the best-character-
ized models of acute gene activation in mammals.
Transcriptional activation of human Ifnb1 requires the
concerted actions of virus-activated and constitutive transcrip-
tion factors to assemble an enhanceosome complex at a
nucleosome-free region upstream of the transcriptional start
site (TSS), which is obscured by a well-positioned nucleosome
(Thanos and Maniatis, 1995; Lomvardas and Thanos, 2002).
The assembled enhanceosome factors recruit coactivators,
including chromatin-remodeling machinery that expose the
TSS for de novo recruitment of Pol II and associated transcrip-
tional machinery, ultimately initiating Pol II transcription (Agalioti
et al., 2000; Lomvardas and Thanos, 2001).
Two essential enhanceosome factors, the transcription fac-
tors interferon regulatory factor 3 (IRF3) and nuclear factor kB
(NFkB), exist in latent cytoplasmic forms. Stimuli that evoke
strong immune and/or inflammatory responses activate these
factors to translocate to the nucleus and bind to their cognate
recognition elements in target gene promoters (Chen and
Greene, 2004; Honda and Taniguchi, 2006). These two proteins
are critical regulators of immunity and inflammatory responses,
control diverse normal cellular functions, and aberrations in their
activity contribute to pathologies including inflammatory dis-
eases and cancer.
Despite the wealth of information regarding the ability of IRF3
and NFkB to regulate the expression of Ifnb1 and other individual
target genes, their relative contributions to overall virus-acti-
vated transcription, their degree of overlap within the antiviral
gene regulation network, and their breadth of target sites
throughout the genome are underinvestigated. The mechanisms
used in regulating antiviral Pol II recruitment, initiation, and elon-
gation at specific targets, aswell as their abilities to regulate non-
coding and protein-coding genes remain poorly understood. A
comprehensive chromatin immunoprecipitation sequencing
(ChIP-seq) study was carried out to directly address these ques-
tions and provide a detailed and quantitative genome-wide anal-
ysis of transcriptional regulation of the cellular antiviral response.
This study reveals extensive collaboration of IRF3 and NFkBwith
Mediator throughout the genome and implicates additional
transcription factor partners for antiviral responses. Moreover,
analysis of Pol II occupancy and elongation during virus infection
indicates that IRF3 and NFkB drive both de novo polymerase
recruitment and mediate the release of paused Pol II at their
target sites, stimulating the expression of a variety of protein-
coding, noncoding, and diverse unannotated loci.
RESULTS
Genome-wide Analysis of IRF3 and p65/RELA
IRF3 and p65/RELA are activated by virus infection and rapidly
associate with target gene regulatory regions. To investigate
the generality of this transcriptional paradigm in antiviral re-
sponses, ChIP-seq was used to determine the genome-wide oc-960 Cell Reports 4, 959–973, September 12, 2013 ª2013 The Authorcupancy of IRF3, p65/RELA, MED1, NELFA, total Pol II (all),
which serves as a marker for transcription initiation and
elongation, and Ser2-phosphorylated Pol II (S2P), an indicator
of productive transcription elongation. In the human Namalwa
B lymphocytic cell line, recruitment of IRF3 and p65/RELA to
the Ifnb1 gene promoter occurs within 1 hr of Sendai virus
infection (Figures S1A–S1D). Virus-induced recruitment of
general transcriptional machinery to the Ifnb1 promoter,
marked by occupation with Pol II, the negative elongation factor,
NELFA, and a representative subunit of the Mediator complex,
MED1, was observed at the promoter, and both Pol II and
MED1 are later detected throughout the gene body (Figures
S1E–S1N).
To capture initial antiviral transcriptional responses, ChIP-seq
libraries were prepared from mock-infected cells or cells in-
fected for 4 hr with Sendai virus. As an additional control, non-
precipitated input DNA was isolated under the same conditions
and subjected to sequencing. As a quality control measure for
every ChIP DNA library, ChIP-quantitative PCR (qPCR) was per-
formed to evaluate an aliquot of the ChIP DNA to validate known
protein binding sites (Figures S1O and S1P). The remainder of
the library was used to produce paired-end sequence tags that
were mapped to the human genome (hg19), producing 4.5–32
million mapped reads for the six factors in both uninfected and
infected conditions (data for all libraries can be found in Table
S1). Regions with statistically significant factor occupancy rela-
tive to input DNA were identified using the model-based analysis
of ChIP-seq (MACS) program (p value < 1 3 105; Table S1;
Zhang et al., 2008).
In the absence of virus infection, few specific genomic loci
were occupied with significant amounts of IRF3 or p65/RELA.
After virus infection, the genome-wide occupancy of IRF3 and
p65/RELA was dramatically elevated, giving rise to clear locus-
specific binding relative to the surrounding genomic region ±
2.5 kb from the peak center (Figures 1A and 1E).Most sites occu-
pied by virus-activated IRF3 or p65/RELA were not bound in the
absence of infection (Figure S2). Furthermore, the loci occupied
by virus-activated IRF3 or p65/RELA are sequences that exhibit
high average conservation scores among vertebrates relative to
the surrounding regions (Figures 1B and 1F; Siepel et al., 2005),
highlighting the importance of gene regulation by IRF3 or p65/
RELA throughout the evolution of innate antiviral responses.
Virus-induced IRF3 or p65/RELA binding sites were analyzed
with respect to the positions of annotated genomic features (Fig-
ures 1C and 1G). Unexpectedly, in light of the known activity of
IRF3 and p65/RELA in driving the inducible expression of
protein-coding genes, virus-activated binding within proximal
promoter regions (defined as 1 kb to +100 bp from the nearest
TSS) was the third most common area occupied by IRF3 or p65/
RELA, comprising only 5.7% and 3.8% of all induced binding
sites, respectively (Figures 1C and 1G). Intergenic regions
(defined as greater than 1 kb from annotated genes) were the
most frequently occupied by both IRF3 and p65/RELA, repre-
senting 46.4% and 47.8% of the inducibly bound loci, respec-
tively. Intronic regions were the second most frequent binding
site category, representing 45.4% and 41.9% of the bound
IRF3 and p65/RELA loci. Among the remaining inducibly
bound sites for IRF3 or p65/RELA, 1.6% and 2.0% were locateds
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Figure 1. Virus Activation of IRF3 and p65/RELA Leads to Widespread Genome Occupancy
(A) Plot of the mean IRF3 sequencing tag density at steady state (dashed) and following virus infection (solid) for 4,316 genomic loci that exhibitR2-fold increase
in occupancy following Sendai infection, respectively (p value < 13 105). ChIP-seq enrichment signals are grouped into 10 bp bins and graph illustrates 2.5 kb
from the peak center. Graphical representation of factor binding displayed under the plot.
(B) Plot of the mean conservation scores at the differentially occupied IRF3 regions defined in (A). Conservation score (grouped into 10 bp bins) represents the
probability that a DNA sequence lies within a conserved element across all vertebrates (Siepel et al., 2005).
(C) Pie chart illustrating the annotation distribution of the differentially bound IRF3 regions described in (A). Binding sites are mapped to one of six annotation
categories: Promoter (1 kb to +100 bp), TTS (100 bp to +1 kb), exon, intergenic, intron, and noncoding, with the percentage of sites corresponding to each
category displayed in parentheses near the label.
(D) Boxplot of IRF3 sequence reads ± 1 kb centered at regions defined in (A), which are divided into TSS (<5 kb from TSS) and distal (>5 kb from TSS) regions.
Changes between mean levels are significant (Welch’s two-tailed t test) at TSSs (p value < 2.2 3 1016) and distal regions (p value < 2.2 3 1016).
(E) Plot of the mean p65/RELA sequencing tag density at steady state (dashed) and following virus infection (solid) for 596 genomic loci that exhibit R2-fold
increase in occupancy following Sendai infection, respectively (p value < 1 3 105). Data displayed as defined in (A).
(F) Plot of the mean conservation scores at the differentially occupied p65/RELA regions defined in (E). Data displayed as defined in (B).
(G) Pie chart illustrating the annotation distribution of the differentially bound p65/RELA regions described in (E). Data displayed as defined in (C).
(H) Boxplot of p65/RELA sequence reads ± 1 kb centered at regions defined in (E), which are divided into groups defined in (D). Changes betweenmean levels are
significant (Welch’s two-tailed t test) at TSSs (p value < 2.2 3 1016) and distal regions (p value < 2.2 3 1016).
See also Figures S1 and S2 and Tables S1 and S2.within 100 bp to +1 kb from transcription termination sites
(TTS), 2.4% and 2.3% within exons, and 0.4% and 0.3% within
noncoding regions. In addition, significant virus-induced IRF3
and p65/RELA sequence tag enrichment was observed in re-
gions either close to (±5 kb) or distant from (>5 kb) the nearest
TSS (Figures 1D and 1H). This analysis demonstrates that a large
proportion of virus-activated IRF3 or p65/RELA binding sites
occur in poorly defined regions of the genome, which are likely
to represent enhancer regions or previously uncharacterized
sites of antiviral transcription initiation. These findings are highly
reproducible, and the sequence tag density at the identified
peaks is significantly correlated for each factor analyzed in bio-
logical replicate samples (Figure S2E).
Motif Enrichment Indicates Cooperativity between IRF3
and p65/RELA and Reveals Regulatory Partners
Numerous studies have demonstrated that IRF and NFkB tran-
scription factors have strong consensus binding sequences
(Sen and Baltimore, 1986; Au et al., 1995; Chen et al., 1998;
Escalante et al., 1998; Lin et al., 2000; Panne et al., 2007;CelWong et al., 2011). DNA sequences within 50 bp from the peak
center at 4,316 IRF3 or 596 p65/RELA bound regions that exhibit
a greater than 2-fold increase in occupancy following virus infec-
tion (p value < 13 105; Table S2) were analyzedwith amotif dis-
covery algorithm to reveal motifs that could indicate potential
antiviral regulatory partners (Heinz et al., 2010). As anticipated,
IRF3 or p65/RELA recognition sequences were identified as
the most significant motifs underlying their respective peaks
(Figure 2A, top and bottom), and a variety of motif examples
matching these canonical binding elements were found (Figures
S3A and S3B). This unbiased approach validates the integrity
and specificity of the ChIP-seq data.
In addition to the consensus IRF3 recognition motif, a number
of highly enriched (p value < 1 3 1050) DNA sequence motifs
were identified, underlying IRF3-occupied sites (Figure 2A, mid-
dle). Themost frequently occurringmotif in IRF3 targetsmatches
the consensus sequence for an E-box element (p = 1 3 10168),
which can be bound by transcription factors containing the basic
helix-loop-helix protein structural motif (Massari and Murre,
2000). E-box proteins have not previously been linked to IRF3l Reports 4, 959–973, September 12, 2013 ª2013 The Authors 961
895
1 2 3 4 5 6 7 8 9 10
Position
0
0.5
1
1.5
2
B
its
2,801
1,515
0
0.001
0.002
0.003
-2500 -1250 0 +1250 +2500
N
or
m
al
iz
ed
 M
ot
if 
Fr
eq
ue
nc
y
Distance from IRF3 Peaks (bp)
Motif 1P Value = 1 x 10-295
0
0.5
1
1.5
2
B
its
1 2 3 4 5 6 7 8 9 10
Position
P Value = 1 x 10-168
11 12
1,571
2,745
0.0015
0.0040
0.0065
0.0090
-2500 -1250 0 +1250 +2500
Distance from IRF3 Peaks (bp)
Motif 2
1 2 3 4 5 6 7 8 9 10
Position
11 12
0
0.5
1
1.5
2
B
its
P Value = 1 x 10-118
3,421
0
0.001
0.002
-2500 -1250 0 +1250 +2500
Distance from IRF3 Peaks (bp)
Motif 3
1 2 3 4 5 6 7 8 9 10
Position
11 12
0
0.5
1
1.5
2
B
its
P Value = 1 x 10-98
0
0.0035
0.0070
-2500 -1250 0 +1250 +2500
Distance from p65 Peaks
Motif 1
248
348
Mock SeV
IRF3
-
3 +3
Mo
tif
-
3 +3
Mo
tif
Mock SeV
IRF3
Mock SeV
IRF3
Mock SeV
p65
-
3 +3
Mo
tif
89
5 
Di
ffe
re
nt
ia
lly
 B
ou
nd
 M
ot
ifs
 
(in
 S
eV
 in
fec
ted
 ce
lls
)
2,
74
5 
D
iff
er
en
tia
lly
 B
ou
nd
 M
ot
ifs
 
(in
 S
eV
 in
fec
ted
 ce
lls
)
1,
51
5 
D
iff
er
en
tia
lly
 B
ou
nd
 M
ot
ifs
 
(in
 S
eV
 in
fec
ted
 ce
lls
)
Distance from Motif (kb)
Distance from Motif (kb)
Distance from Motif (kb)
Mock SeV
IRF3
Mock SeV
p65
-
3 +3
Mo
tif
Distance from Motif (kb)
24
8 
Di
ffe
re
nt
ia
lly
 B
ou
nd
 M
ot
ifs
 
(in
 S
eV
 in
fec
ted
 ce
lls
)
Mock SeV
p65
Mock SeV
p65
A B C DIRF3
Motif1 = IRF3
IRF3
Motif2 = E-Box
IRF3
Motif3 = p65
p65
Motif1 = p65
IRF3
Motif1
IRF3
Motif2
IRF3
Motif3
p65
Motif1
0
2
4
6
Mock - p65 SeV - p65
p6
5 
(T
ag
s/1
07 /
bp
)
E
F
0
3
6
9
Mock - IRF3 SeV - IRF3
IR
F3
 (T
ag
s/1
07 /
bp
)
IRF3 Binding Sites
p65 Binding Sites
N
or
m
al
iz
ed
 M
ot
if 
Fr
eq
ue
nc
y
N
or
m
al
iz
ed
 M
ot
if 
Fr
eq
ue
nc
y
N
or
m
al
iz
ed
 M
ot
if 
Fr
eq
ue
nc
y
Figure 2. Enriched Sequence Motifs Demonstrate IRF3 and p65/RELA Co-occupancy and Identify Potential Regulatory Partners
(A) Graphical representations of the most frequent DNA sequence motifs identified within the 4,316 differentially occupied IRF3 or 596 p65/RELA regions
determined by the de novo motif discovery algorithm in the software suite HOMER (Heinz et al., 2010). Each DNA logo represents the information content/bp by
height, with the p value indicating statistical significance for the motif enrichment. P values and the representative motif name found in the databases (JASPAR,
Transfac, and HOMER) are displayed above their corresponding motif.
(B) Pie charts representing the frequency of each motif at the regions defined in (A) (±100 bp from each peak center). Colored sections indicate the fraction of all
differentially bound IRF3 (black) or p65/RELA (blue) genomic sites that contain at least one match to the indicated DNA sequence motif. The number of regions in
which a match is present or absent is indicated.
(C) Plot of the mean motif density at the regions defined in (A) within 2.5 kb of the peak center. Motif density signals are grouped into 10 bp bins.
(D) Heatmap representation of IRF3 (black) and p65/RELA (blue) occupancy levels at the differentially occupied loci defined in (A) that encompasses the identified
motif. Data are organized to illustrate 3 kb surrounding the motif center. Occupancy levels are rank ordered from most to least occupied according to the
indicated factor.
(E and F) Boxplots of p65/RELA (E) and IRF3 (F) sequence reads ± 1 kb centered on the regions defined in (A). Changes between mean occupancy levels are
significant for both p65/RELA (p value < 2.2 3 1016) and IRF3 (p value < 2.2 3 1016; Welch’s two-tailed t test)
See also Figure S3 and Tables S1 and S2.and antiviral responses, but the E-box regulatory element has
been previously described as a transcriptional partner for other
members of the IRF family, specifically, IRF1 and IRF4, and
this association is critical for CIITA gene activation by IFNg and
pre-B cell development, respectively (Muhlethaler-Mottet et al.,
1998; Gobin et al., 2003; LeibundGut-Landmann et al., 2004;
van der Stoep et al., 2004; Lazorchak et al., 2006). The E-box
motif was found in 2,475 (57.3%) IRF3-bound regions within ±
50 bp proximity to the IRF3 binding sites (Figures 2B and 2C,
2nd row). The next most significant non-IRF3 motifs corre-
sponded to p65/RELA binding sequences. Consideration of all962 Cell Reports 4, 959–973, September 12, 2013 ª2013 The Authorp65-binding motif variants that lie within ± 750 bp of the nearest
IRF3 binding site reveals over 76% co-occurrence. The most
frequent p65 consensus motif (p = 1 3 10118; Figure 2, row 3)
is observed at 895 (20.7%) IRF3-bound sites within ± 50 bp prox-
imity to the IRF3-occupied loci (Figures 2B and 2C, 3rd row).
Throughout the genome, a majority of IRF3- or p65/RELA-
bound loci investigated are co-occupied by the other antiviral
transcription factor (Figure2D)with a significant level of sequence
tag enrichment (Figures 2E and 2F), indicating these factors work
together globally to initiate the transcriptional regulatory network
of the innate immune response. Significant enrichment of cyclics
AMP response elements (CRE, p = 1 3 1075) and consensus
E-twenty-six (ETS)-binding motifs (p = 1 3 1052; Figures S3C
and S3D) suggests extensive crosstalk and coordination
between the master antiviral factors and other essential cellular
regulatory pathways during the onset of virus infection.
De Novo Assembly of Transcriptional Machinery at IRF3
and p65/RELA Target Sites
IRF3 and NFkB are able to initiate recruitment of general tran-
scription machinery at the Ifnb1 promoter in response to virus
infection. To consider how these antiviral transcription factors
and transcriptionmachinery cooperate genome-wide to regulate
antiviral target genes, ChIP-seq analysis focused on virus-
induced target genes using strictly defined stringencies to deter-
mine differential binding sites for each factor, ensuring that the
investigation focused on genomic regions of high confidence
(Tables S2 and S3). The number of occupied loci was highest
for Pol II (S2P), Pol II (all), and NELFA (55,493, 28,182, and
12,769, respectively), presumably because of their more general
roles in transcription regulation. MED1 occupied an intermediate
number of loci (3,752), similar to the numbers observed for IRF3
and p65/RELA (6,141 and 1,107, respectively), though it is
important to note that some variations in binding site frequency
and signal strengthmay be due to the technical limitations result-
ing from differences in antibody efficiency, direct versus indirect
DNA binding, or other experimental idiosyncrasies.
To examine the overlap among all six factors, analysis was
restricted to loci exhibiting a greater than 4-fold increase in signal
following infection (IRF3 [n = 3,392], p65/RELA [n = 471], MED1
[n = 819], or Pol II [All; n = 3,449]). The occupancy of the other five
factors relative to these differentially bound regions was deter-
mined (Figure 3). The results revealed that, in general, the indu-
cibly occupied genomic sites are cobound by all of the factors
at precisely the same positions (Figures 3A and 3B). However,
there are variances in the degree of factor recruitment at the
differentially bound factor sites.
For example, virus-induced IRF3-bound sites were co-occu-
pied by p65/RELA and associated with dramatic increases in
MED1, NELFA, Pol II (all), and Pol (S2P) occupancy (Figures 3A
and 3B, top). Similarly, sites of newly bound p65/RELA were
co-occupied by IRF3 and associated with increases in transcrip-
tional machinery occupancy, albeit to a lesser degree than IRF3
target loci (Figures 3A and 3B, 2nd row). These data suggest that
an array of genomic sites bound by both virus-activated factors
can recruit regulatory machinery to initiate transcription. Regions
of newly bound MED1 are co-occupied by IRF3 and p65/RELA
and also correspond to elevated NELFA, Pol II (all), and Pol II
(S2P) occupancy, verifying through an unbiased approach that
newly bound MED1 sites are inextricably linked to loci bound
by virus-activated IRF3 and p65/RELA (Figures 3A and 3B, 3rd
row). Similarly, sites of newly bound Pol II showcase the co-
occupancy of IRF3 and p65/RELA and are marked by dramatic
increases in MED1, NELFA, and Pol II (S2P) occupancy. This
analysis reveals extensive genome-wide IRF3 and p65/RELA
collaboration and suggests that they can recruit Mediator to
direct the transcriptional response of infected cells.
Organizing the variety of binding patterns at highly induced
loci through k-means clustering provided even greater insightsCelinto coregulation of antiviral gene expression. IRF3 and p65/
RELA co-occupy virtually every inducible IRF3 or p65/RELA
region, but virus-inducible recruitment of transcriptional machin-
ery is not always apparent at these sites (Figure 3C, 1st row
[cluster 9] and 2nd row [clusters 1, 4, 9, and 10]). Inducibly bound
MED1 regions reveal a small subset that was not occupied by
IRF3 or p65/RELA (Figure 3C, 3rd row [cluster 6]). These regions
do not exhibit increased occupancy of Pol II and its coassociated
pausing factor, NELFA, suggesting that a subset of MED1 is re-
organized during infection without the support of IRF3 and/or
p65/RELA and may function in a context independent of the
general transcription machinery. Clustering of the inducibly
bound Pol II (all) sites revealed only a small portion of loci that
are not co-occupied by IRF3, p65/RELA, MED1, or NELFA (Fig-
ure 3C, bottom row [clusters 1 and 4]). These loci can be ex-
plained by at least two distinct mechanisms, including: (1) Pol
II recruitment independent of IRF3, p65/RELA, and MED1 or (2)
IRF3, p65/RELA, and MED1 participate in Pol II recruitment but
either transiently or distal to the defined region.
Genome-wide and Contextual Colocalization of
Virus-Activated Transcription Machinery
To examine the spatial relationship between all six factors
throughout the infected cell genome, the total binding sites of
each protein were evaluated relative to annotated genes to
reveal similarities and differences in their binding sites (Fig-
ure 4A). Whereas IRF3, p65/RELA, MED1, and Pol II (S2P)
were largely bound outside of proximal promoters in intergenic
and intronic regions (91.7%, 92.5%, 86.1%, and 84.9% of
sites, respectively), Pol II (all) and NELFA were more commonly
associated with promoters (18.0% and 42.1% of sites, respec-
tively). These data demonstrate that all of the factors do not
solely bind to promoters but rather a variety of genomic loca-
tions. A majority of Pol II (all) and NELFA is found within 5 kb of
the nearest TSS, whereas Pol II (S2P) binding sites largely lie
downstream of the nearest TSS (Figure 4B; Table S4). Similar
distributions of IRF3, p65/RELA, and MED1 were found with a
large fraction of occupied sites greater than 10 kb from an
annotated TSS.
Pairwise analysis of inducibly bound peaks in every data set
demonstrates that all of the tested factors share significant levels
of coassociation to one another genome-wide (Figure 4C, left
chart). This coassociation reflects both known interactions,
such as that between Pol II (all) and NELFA, as well as unex-
pected associations, like that of IRF3 and p65/RELA with
MED1. An oriented coassociation analysis focused on promoter
regions (defined as ±2 kb surrounding the TSS) and distal re-
gions (defined as >10 kb from an annotated TSS). Distinct and
specific patterns of coassociation were identified for a subset
of factors. For example, at distal regions, increased association
between IRF3 orMED1with NELFA and Pol II (all) were detected,
suggesting that these factors function together outside of anno-
tated regions of the genome to initiate antiviral transcription.
Additionally, IRF3 and p65/RELA share a stronger relationship
around the promoters of genes than they do at distal regions,
suggesting that, whereas they occupy and regulate a similar
set of genes, they bind to distinct targets in unannotated
genomic regions during the early innate antiviral response.l Reports 4, 959–973, September 12, 2013 ª2013 The Authors 963
00.2
0.4
0.5
0.7
-2500 -1250 0 +1250 +2500N
or
m
al
iz
ed
 C
hI
P-
se
q 
Ta
g 
De
ns
ity
Mock
SeV
p65
MED1
NELFA
IRF3
Distance from IRF3 Bound Sites (bp)
A
0
0.5
1.0
1.5
2.0
-2500 -1250 0 +1250 +2500N
or
m
al
iz
ed
 C
hI
P-
se
q 
Ta
g 
De
ns
ity
B
IRF3
Distance from IRF3 Bound Sites (bp)
Mock
SeV
Pol II
Pol II (S2P)
C
Distance from IRF3 bound sites (kb)
Mock SeV
IRF3 p65 MED1 NELFA Pol II (All) Pol II (S2P)
Pe
ak
 Ce
nte
r
-
3 +3
3,
39
2 
Di
ffe
re
nt
ia
lly
 B
ou
nd
 IR
F3
 S
ite
s 
(in
 S
eV
 in
fec
ted
 ce
lls
)
2
3
4
5
6
7
8
9
10
Mock SeV Mock SeVMock SeVMock SeVMock SeVCluster
1
0
7.5
15.0
22.5
30.0
-2500 -1250 0 +1250 +2500N
or
m
al
iz
ed
 C
hI
P-
se
q 
Ta
g 
De
ns
ity
IRF3
MED1
NELFA
Mock
SeV
0
7.5
15.0
22.5
30.0
-2500 -1250 0 +1250 +2500N
or
m
al
iz
ed
 C
hI
P-
se
q 
Ta
g 
De
ns
ity
Mock
SeV
Pol II
Pol II (S2P)
p65
Distance from p65 Bound Sites (bp)
p65
Distance from p65 Bound Sites (bp)
Mock SeV
IRF3 p65 MED1 NELFA Pol II (All) Pol II (S2P)
Mock SeV Mock SeVMock SeVMock SeVMock SeV
Distance from p65 bound sites (kb)
47
1 
D
iff
er
en
tia
lly
 B
ou
nd
 p
65
 S
ite
s 
(in
 S
eV
 in
fec
ted
 ce
lls
)
2
3
4
5
6
7
8
9
10
Cluster
1
0
7.5
15.0
22.5
30.0
-2500 -1250 0 +1250 +2500N
or
m
al
iz
ed
 C
hI
P-
se
q 
Ta
g 
De
ns
ity
MED1
Distance from MED1 Bound Sites (bp)
Mock
SeV
IRF3
p65
NELFA
0
7.5
15.0
22.5
30.0
-2500 -1250 0 +1250 +2500N
or
m
al
iz
ed
 C
hI
P-
se
q 
Ta
g 
De
ns
ity
MED1
Distance from MED1 Bound Sites (bp)
Distance from MED1 bound sites (kb)
81
9 
Di
ffe
re
nt
ia
lly
 B
ou
nd
 M
ED
1 
Si
te
s 
(in
 S
eV
 in
fec
ted
 ce
lls
)
2
3
4
5
6
7
8
9
10
Cluster
1
Mock SeV
IRF3 p65 MED1 NELFA Pol II (All) Pol II (S2P)
Mock SeV Mock SeVMock SeVMock SeVMock SeV
0
0.175
0.350
0.525
0.700
-2500 -1250 0 +1250 +2500N
or
m
al
iz
ed
 C
hI
P-
se
q 
Ta
g 
De
ns
ity
0
0.175
0.350
0.525
0.700
-2500 -1250 0 +1250 +2500N
or
m
al
iz
ed
 C
hI
P-
se
q 
Ta
g 
De
ns
ity
Pol
II
Distance from Pol II Bound Sites (bp)
Pol
II
Distance from Pol II Bound Sites (bp)
Distance from Pol II (All) bound sites (kb)
Mock SeV
IRF3 p65 MED1 NELFA Pol II (All) Pol II (S2P)
3,
44
9 
Di
ffe
re
nt
ia
lly
 B
ou
nd
 P
ol
 II
 S
ite
s 
(in
 S
eV
 in
fec
ted
 ce
lls
) 2
3
4
5
6
7
8
9
10
Mock SeV Mock SeVMock SeVMock SeVMock SeVCluster
1
Mock
SeV
Pol II
Pol II (S2P)
Mock
SeV
Mock
SeV
NELFA
Pol II (S2P)
IRF3
p65
MED1
n = 3,392
n = 471
n = 819
n = 3,449
Pe
ak
 Ce
nte
r
-
3 +3
Pe
ak
 Ce
nte
r
-
3 +3
Pe
ak
 Ce
nte
r
-
3 +3
Figure 3. Coordinated De Novo Assembly of Pol II and General Transcription Machinery with IRF3 and p65/RELA
(A) Plot of the mean IRF3 (black), p65/RELA (blue), MED1 (green), and NELFA (purple) sequence tag density at steady state (dashed lines) and following Sendai
virus infection (solid lines). Only loci that exhibitR4-fold increase in occupancy following infection were included (p value < 13 105); for IRF3 (n = 3,392), p65/
RELA (n = 471), MED1 (n = 819), or Pol II (all; n = 3,449). ChIP-seq enrichment signals are grouped into 10 bp bins and graphs illustrate ± 2.5 kb. Graphical
representation of bound factor displayed under plot.
(B) Plot of themeanNELFA (purple), Pol II (all; red), and Pol II (S2P; teal) sequence tag density at steady state (dashed) and following Sendai virus infection (solid) at
differentially bound loci defined in (A). Graphical representation of bound factor displayed under plot.
(C) Heatmap representation of IRF3 (black), p65/RELA (blue), MED1 (green), NELFA (purple), Pol II (all; red), and Pol II (S2P; teal) occupancy levels at the
differentially occupied loci defined in (A). Occupancy levels are rank ordered from most to least occupied according to the indicated factor and then divided into
ten sections by k-means clustering analysis. Three kilobases surrounding the peak center (arrow) are illustrated.
See also Tables S1, S2, and S3.IRF3 and p65/RELA Participate in Diverse Pol II
Regulatory Paradigms
The virus activation of Ifnb1 gene expression is well known to
feature recruitment of Pol II de novo. The recent appreciation
that Pol II regulatory mechanisms involving pause and release
are widespread in diverse metazoans led to comparison of964 Cell Reports 4, 959–973, September 12, 2013 ª2013 The Authorvirus-induced Pol II pause release versus de novo Pol II recruit-
ment genome-wide and at specific target genes. To determine
if virus-activated transcription factors contribute topause release
of their target genes, ChIP-seq data were analyzed to determine
the fraction of genes bound by IRF3 or p65/RELA that were asso-
ciated with increased levels of Pol II (all) and Pol II (S2P), as ans
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Figure 4. Genome-wide Occupancy and Colocalization of Virus-Induced Transcription Factors with General Transcription Machinery
(A) The distribution of genomic sites bound by IRF3, p65/RELA, MED1, NELFA, Pol II (all), and Pol II (S2P) in Sendai virus-infected cells.
(B) Distribution of virus-induced factor binding sites relative to the nearest annotated TSS.
(C) Graphical representation of the coassociation of virus-induced factors. The color strength represents the extent of association from red (strongest) to yellow
(weakest). Left: whole genome analysis reveals factors have nonrandom associations with each other. Oriented analysis of promoter proximal (i.e., within 2 kb
from the nearest TSS) or distal associations (i.e., >10 kb from the nearest TSS) reveals more specific relationships (center and right, respectively).
See also Tables S1, S2, and S4.indication of active transcription. Nearly all IRF3-occupied sites
and a majority of all p65/RELA-occupied loci show evidence of
transcription elongation, indicating thatmost of the regions asso-
ciated with these transcription factors are transcriptionally active
(Figures 3A and 3B). Both IRF3 and p65/RELA target genes
exhibit a substantial virus-induced increase in total Pol II and
Ser-2-phosphorylated Pol II within the gene body, whereas the
promoter proximal Pol II (all) remained largely unaffected (Fig-
ure 5A). The similar overall magnitude of evidence for pausing
phenomena at both IRF3 and p65/RELA targets suggests they
may share similar abilities to promote Pol II elongation. In addi-
tion, a global increase in Pol II elongation following virus infection
was observed, most likely due to the dramatic increases in tran-
scriptional load at the virus-activated target genes (Figure S4A).
Calculated pausing ratio values (PR; see Experimental Proce-
dures) for IRF3 and p65/RELA target genes decreased as a result
of virus infection (FigureS4B). The similarity inPol II pause release
found between the two data sets is, in part, a result of the overlap
in target genes between the two factors.
Despite this evidence for release of paused Pol II, IRF3, and
p65/RELA, both have been associated with promoting the de
novo recruitment of Pol II and general transcription machinery
to activated genes (Lenardo et al., 1989; Wathelet et al., 1998;
Sato et al., 2000; Wietek et al., 2003; Leung et al., 2004; Ogawa
et al., 2005). To determine the extent of IRF3 or p65/RELA-medi-
ated de novo recruitment, 200 TSSs demonstrating the greatest
increase in factor occupancy following virus infection (ranked by
factor levels within 2 kb of annotated TSSs) were examined
(Figures 5B and 5C). The proximal promoter regions of virus-
activated IRF3 target genes were largely devoid of Pol II in the
uninfected cells but exhibited dramatically increased levels ofCelPol II (all) and Pol II (S2P) occupancy after virus infection. In stark
contrast, Pol II occupied the proximal promoters of p65/RELA
target genes to similar levels, irrespective of virus infection.
Both sets of target genes were marked by virus-induced in-
creases of all forms of Pol II in the gene bodies. These data indi-
cate that IRF3 ismore competent than p65/RELA in recruiting the
Pol II transcription machinery to the promoters of genes not pre-
viously bound by Pol II and its associated factors, whereas p65/
RELA is an effector of pause release.
Detailed examination of three target genes (Ifnb1, Isg15, and
B2m) provides clear examples of both pause release and de
novo Pol II recruitment mechanisms underlying antiviral target
gene regulation (Figure 5D). Ifnb1 and Isg15 display varying
levels of de novo Pol II recruitment and pause release, with the
Ifnb1 gene harboring no Pol II and the Isg15 gene containing
limited Pol II occupancy prior to infection.B2m shows all the hall-
marks of pause release after infection, with increased Pol II levels
in the gene body, similar Pol II levels in the promoter, and a signif-
icantly decreased PR value after activation. PR values are given
for all annotated genes in the human genome before and after
infection in Table S5.Together, the association of IRF3 or p65/
RELA with a substantial fraction of actively transcribed genes
containing promoter-bound NELF and virus-induced decreases
of PR values is consistent with themodel that both IRF3 and p65/
RELA contribute to Pol II pause release at a large portion of
genes in virus-infected cells.
IRF3 and p65/RELA Are Primary Drivers of Innate
Antiviral Transcription
Analysis of DNA sequences underlying virus-induced occupancy
of MED1, NELFA, and Pol II sites was carried out to reveal thel Reports 4, 959–973, September 12, 2013 ª2013 The Authors 965
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Figure 5. Activated IRF3 Participates in Diverse Pol II Regulatory Paradigms
(A) Pol II pause release is a general feature of virus-induced gene expression. Plot of mean Pol II (all; red) and Pol II (S2P; teal) sequence tag density at steady state
(dashed lines) and following Sendai virus infection (solid lines). Data are displayed in a 50 kb window surrounding the TSSs and TTSs of all IRF3 (top) or p65/RELA
(bottom) target genes that exhibitR4-fold increase in factor occupancy following Sendai virus infection (p value < 1 3 105). ChIP-seq enrichment signals are
grouped into 150 bp bins.
(B and C) De novo Pol II recruitment to IRF3 (B) and p65/RELA (C) target promoters. Plot of mean IRF3 (black), p65/RELA (blue), MED1 (green), NELFA (purple),
Pol II (all; red), and Pol II (S2P; teal) sequence tag density at steady state (dashed lines) and following Sendai virus infection (solid lines). Data are displayed in a
10 kb window surrounding the TSSs of 200 promoters containing the greatest increases in IRF3 (B) or p65/RELA (C) occupancy after virus infection. ChIP
enrichment signals are grouped into 25 bp bins.
(D) Gene browser views of specific examples of virus-dependent recruitment of transcriptional machinery with distinct Pol II regulatory mechanisms. Displayed
are the virus-induced Ifnb1 (left), Isg15 (middle), and B2m (right) genes with their corresponding PR values.
See also Figure S4 and Tables S1, S2, S3, S4, and S5.primary transcription factor motifs that drive antiviral tran-
scription regulation. The DNA sequences within 100 bp from
the peak center at 1,377 MED1, 1,247 NELFA, or 4,335 Pol II
(all) regions with >2-fold increase in occupancy following Sendai
virus infection (p value < 1 3 105; Table S2) were subjected
to de novo motif discovery. For MED1, two motifs were recog-
nized. Motif 1 is a consensus IRF-binding interferon-stimulated
response element (Honda and Taniguchi, 2006) and was identi-
fied in 815 (59.2%) MED1-bound loci. Motif 2 represents a
consensus p65-binding REL element (Chen and Greene, 2004)
and was identified in 411 (29.8%) MED1-bound loci. The IRF-
binding motifs were also significantly enriched in all the differen-
tially bound data sets (Figure 6A) and was found in 319 (25.6%)
NELFA sites, which also display a second IRF half-site motif and
1,092 (25.2%) Pol II-bound loci. In all cases, the motif is found in966 Cell Reports 4, 959–973, September 12, 2013 ª2013 The Authorclose association to the ChIP-seq peak center (Figures 6B and
6C, top and bottom two rows).
To test whether the identified sequence motifs were occupied
by their cognate transcription factor, the occupancy of each fac-
tor was plotted within 3 kb of themotif (Figure 6D). In general, the
identified sequence motif-containing loci were all found to be
associated with the corresponding transcription factor and
were also associated with surrounding increases in occupancy
by transcriptional machinery (Figure 6D, all rows), validating
that these sequences play a vital role in recruiting transcription
factors to facilitate transcription. These findings support theover-
all conclusion that IRF3 and p65/RELA are master transcription
factors that drive the innate antiviral gene regulatory response.
To understand biological pathways that are affected by gene
transcription during the early stages of virus infection, geness
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Figure 6. IRF3 Acts as a Master Regulator of Innate Immunity-Activated Transcriptional Networks
(A) Graphical representations of the most frequent DNA sequence motifs identified by HOMER within the 1,377 MED1-, 1,247 NELFA-, or 4,335 Pol II (all)-bound
regions withR2-fold occupancy increase following virus infection (p value < 1 3 105). Each DNA logo represents the information content/bp by height, with
p value indicating statistical significance for the motif enrichment. P values and the representative motif name found in the databases (JASPAR, Transfac, and
HOMER) are displayed above their corresponding motif.
(B) Pie charts representing the genomic DNA sequences of the bound regions described in (A) (±100 bp from each peak center) scanned for matches to each of
the motifs. Pie charts representing the distribution of motifs present in differentially bound MED1, NELFA, or Pol II (all) peaks. Colored sections indicate the
fraction of boundMED1, NELFA, or Pol II (all) genomic sites that contain at least onematch to the indicated DNA sequencemotif. The number of regions in which a
match is present or absent is indicated.
(C) Plot of the mean motif density at bound regions described in (A) within 2.5 kb of the peak center. Motif density signals are grouped into 10 bp bins.
(D) Heatmap representation of IRF3 (black), p65/RELA (blue), MED1 (green), NELFA (purple), Pol II (all; red), and Pol II (S2P; teal) occupancy levels at the
differentially occupied loci defined in (A) that encompasses the identified motif. Data are organized to illustrate 3 kb surrounding the motif center. Occupancy
levels are rank ordered from most to least occupied according to the indicated factor and divided into five or ten sections by k-means clustering analysis.
(E) Enrichment of gene ontology (GO) categories among genes nearest IRF3-, p65/RELA-, MED1-, NELFA-, or Pol II (all)-bound regions demonstratingR4-fold
increase or decrease (as noted) in occupancy following Sendai virus infection (p value < 13 105). Representative GO categories are shown; the complete set of
enriched GO categories is listed in Table S6.
See also Tables S1, S2, and S6.
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inducibly bound by each factor were functionally categorized
using gene ontology (GO) (Harris et al., 2004), and this informa-
tion was used to plot enriched categories (Figure 6E). The com-
plete set of enriched GO categories is listed in Table S6. Results
indicate that each factor converges on regulation of immunolog-
ical and signaling pathways; for example, genes involved in the
innate immune response and related processes were preferen-
tially occupied by each factor (Figure 6E).
Unannotated Sites of Virus-Induced Transcription
Pol II transcribes all protein-coding RNAs as well as an assort-
ment of noncoding RNAs, including those associated with un-
characterized ‘‘intergenic’’ and ‘‘intragenic’’ regions as well as
enhancer-associated transcripts (Kim et al., 2010; Djebali
et al., 2012). The identification of virus-induced binding sites
that are outside of previously annotated regions prompted the
use of ChIP-seq data to identify sites of transcription initiated
in response to virus infection. Inducible IRF3 targets in intergenic
and intragenic loci experienced a concomitant increase in p65/
RELA, MED1, NELFA, and Pol II (all) occupancy, which suggests
that these sites are transcriptionally active (Figures 7A and 7B).
Detailed examination of both IRF3 + p65/RELA and IRF3-only
unannotated target loci indicates that transcription factor bind-
ing promotes the recruitment of transcription machinery and
activation of Pol II (Figures 7C and 7D). These unannotated
regions generate RNA transcripts in response to virus infection,
as detected by specific RT-qPCR (Figure 7E). This demonstrates
that the antiviral response is capable of activating transcription
to produce distinct classes of previously unrecognized RNAs.
For reference, we refer to these RNA species as novel virus-
inducible RNAs or nviRNAs.
The behavior of the identified nviRNA loci was further tested
by direct analysis and independently validated the Sendai
virus-inducible occupancy of IRF3, p65/RELA, and MED1 at
every investigated nviRNA locus, confirming the accuracy of
the ChIP-seq data sets (Figure 8A). Further, most of the tested
nviRNA loci exhibited inducible IRF3, p65/RELA, and MED1
recruitment in response to distinct viruses tested, including
encephalomyocarditis virus (EMCV) and influenza A virus
(A/Udorn/72) (Figure 8B). Each of the nviRNA loci generated
an inducible RNA transcript detected by RT-qPCR in response
to Sendai virus (Figure 8C), influenza A viruses (A/Udorn/72
and A/Wilson-Smith Neurotropic [WSN]/33), vesicular stomatitis
virus (VSV), and EMCV, albeit with some locus-specific differ-
ences in absolute activation levels reflective of activation
kinetics or other parameters (Figure 8D). To test the generality
of nviRNA induction, parallel experiments were carried out in
HeLa cells. Direct analysis by RT-qPCR reveals that a large
majority of the nviRNA loci generate inducible transcripts in
response to diverse virus infections (Figure 8E). The primers
used to investigate these and all other genes/loci in this investi-
gation can be found in Table S7. These findings solidify the
conclusion that these sites of transcription are widely activated
by virus infections and represent an overlooked feature of the
innate antiviral response.
In addition to virus-induced transcription, several intergenic
regions were identified that featured virus-activated IRF3 +
p65/RELA but were constitutively occupied by elongating Pol II968 Cell Reports 4, 959–973, September 12, 2013 ª2013 The Authorand did not recruit additional transcription machinery de novo
(Figure S5, top right). This behavior is not uncommon and is
reflected in clusters 9 and 10 in the differentially bound IRF3-
occupied loci (Figure 3C, IRF3-bound heat maps) and in clusters
1, 2, 4, 9, and 10 in differentially bound p65/RELA-occupied loci
(Figure 3C, p65/RELA-bound heat maps). These data strongly
support a role for IRF3 and NFkB as regulators of a wide range
of known and unknown RNA classes that contribute to the
cellular response to virus infection.
DISCUSSION
Signal-activated transcription factors function independently or
in concert to ensure rapid and specific induction of gene expres-
sion programs. During the transcriptional response to virus infec-
tion, Pol II is recruited to new sites and activated for efficient
elongation by the transcription factors IRF3 and NFkB. Examina-
tion of the occupancy of Pol II and its associated coactivating
partners across the genome revealed that IRF3 and p65/RELA
are responsible for regulating the vast majority of transcriptional
responses to virus infection. Both IRF3 and p65/RELAwere iden-
tified within close proximity to one another’s ChIP-seq peak cen-
ters throughout the human genome and were also identified
within close proximity to the ChIP-seq peak centers of loci with
infection-induced occupation by general transcriptional machin-
ery (MED1 and NELFA) and Pol II. These transcription factors act
in close association with each other to regulate antiviral target
genes and also act independently to regulate specific loci, in
agreement with the designation of IRF3 and NFkB as master
regulators of innate antiviral responses (Honda and Taniguchi,
2006). In addition, subordinate regulators that had not been pre-
viously recognized in the antiviral system were identified, in the
form of E-box, cyclic AMP response element binding (CREB),
and ETS family transcription factors, whose cognate recognition
motifs were highly represented within master regulator ChIP-seq
peaks.
Virus-activated transcription is achieved through two means:
pause release mechanisms that enhance the elongation rate of
promoter-stalled Pol II and de novo recruitment of Pol II and
associated transcriptional machinery. The virus-activated loci
that feature a paused polymerase associated with NELF in the
absence of stimulation undergo a quantifiable increase in poly-
merase elongation after virus infection, as indicated by their
decreased PR values. During the antiviral response, both IRF3
and p65/RELA are recruited to NELFA-occupied loci, and these
loci are heavily enriched for IRF-binding consensus motifs. The
inducible transcription factors set the stage to alleviate the con-
straints of the negative elongation machinery and activate Pol II
for productive transcription.
In addition to activation of paused Pol II, a significant number
of inducible genes were observed to have little or no Pol II
present prior to infection, with substantial increases in Pol II
following exposure to virus. These genes have a high or incalcu-
lable PR at steady state but exhibit high levels of Pol II at the pro-
moter and throughout the gene body after infection. The newly
recruited Pol II is associated with NELFA and Mediator and
rapidly becomes Ser-2 phosphorylated, resulting in productive
transcription.s
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Figure 7. Virus-Activated IRF3 and p65/RELA Initiate Transcription at Genomic Locations
(A and B) Boxplots of indicated sequence reads ± 1 kb centered at IRF3 intergenic (A) or intragenic (B) regions demonstrating R4-fold increase in
occupancy following SeV infection (p value < 13 105). Changes between mean levels are significant for all factors (Welch’s two-tailed t test) at both intergenic
(p value < 2.2 3 1016) and intragenic sites (p value < 2.2 3 1016).
(C and D) Examples of virus-dependent occupancy of IRF3 + p65/RELA (C) or IRF3 (D) targets at unannotated loci. The IRF3, p65/RELA, MED1, NELFA, Pol II (all),
and Pol II (S2P) occupancy at basal state and 4 hr postinfection (p.i.) are illustrated in genome browser views of virus-induced regions in chromosomes 1, 2, and 3.
(E) Induction of nviRNAs by Sendai virus infection. Cells were mock-infected or infected (5 pfu/cell), 53 106 cells were harvested for RNA isolation, and random-
primed RT-PCR was performed with primers for the indicated locus and GAPDH for normalization. Error bars denote standard deviation for triplicate PCR re-
actions. The top four graphs illustrate loci from (C) and (D), and the bottom four graphs show additional regions, including those displayed in Figure S6, and Ifnb1
as a control.
See also Figure S5 and Tables S1, S2, and S7.Evidence for both pause release and de novo Pol II recruitment
was found at IRF3 and p65/RELA target genes, but examination
of highly inducible individual targets of these factors revealed a
clear difference in the predominant mode of Pol II activation
between the two regulators. The p65/RELA target genes were
primarily regulated by pause release, with little change in Pol IICeloccupancy at the promoter following infection. In contrast, the
IRF3 target genes exhibit strong de novo recruitment, with low
levels of Pol II found prior to infection that dramatically increase
after virus-mediated activation. The difference in principal mech-
anisms used for target gene activation may in part explain why
these factors have evolved to coregulate gene expression.l Reports 4, 959–973, September 12, 2013 ª2013 The Authors 969
00.035
0.070
%
 In
p
ut
Mock EMCV Udorn
0
0.05
0.10
0.15
0.20
%
 In
p
ut
0
0.05
0.10
0.15
%
 In
p
ut
Mock EMCV Udorn
Mock EMCV Udorn
p65
IRF3
MED1
0
0.02
0.04
0.06
0.08
%
 In
p
ut
Mock SeV
0
0.1
0.2
0.3
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
%
 In
p
ut
0
0.1
0.2
0.3
%
 In
p
ut
Mock SeV
Mock SeV
p65
IRF3
MED1
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
* 
0
400
800
1200
1600
Mock SeV
IFNB1
R
el
at
iv
e 
A
b
un
d
an
ce
NamalwaC
*
0
50
100
150
200
Mock SeV
Chr 1 (213) *
0
4
8
12
16
20
Mock SeV
Chr 2 **
10
20
30
40
50
Mock SeV
Chr 5
* 
0
200
400
600
800
1000
1200
Mock SeV
Chr 7 * 
0
2
4
6
8
10
12
14
Mock SeV
Chr 9 **
0
2
4
6
8
10
Mock SeV
Chr 10 * 
0
50
100
150
200
250
300
Mock SeV
Chr 12 *
0
5
10
15
20
25
30
Mock SeV
Chr 13 * 
0
2
4
6
8
10
12
14
Mock SeV
Chr 16 (574) * 
0
100
200
300
400
500
Mock SeV
Chr 16 (109)
NamalwaD
R
el
at
iv
e 
A
b
un
d
an
ce
*
* 
*
* 
500
1000
1500
2000
M
oc
k
Ud
or
n
W
SN VS
V
EM
CV
IFNB1
* 
* 
* 
* 
0
10
20
30
40
M
oc
k
Ud
or
n
W
SN VS
V
EM
CV
Chr 1
 (213)
* 
* 
* 
* 
0
5
10
15
20
25
30
35
M
oc
k
Ud
or
n
W
SN VS
V
EM
CV
Chr 2 **
**
**
**
0
30
60
90
120
M
oc
k
Ud
or
n
W
SN VS
V
EM
CV
Chr 5 * 
* 
* 
* 
0
200
400
600
800
Mo
ck
Ud
ornWS
N
VS
V
EM
CV
Chr 7
*
* 
* * 
0
2
4
6
8
10
M
oc
k
Ud
or
n
W
SN VS
V
EM
CV
Chr 9
**
** **
**
0
10
20
30
40
50
60
M
oc
k
Ud
or
n
W
SN VS
V
EM
CV
Chr 10 * 
* 
* 
0
25
50
75
100
M
oc
k
Ud
or
n
W
SN VS
V
EM
CV
Chr 12
* 
* 
* 
* 
0
100
200
300
400
500
600
700
M
oc
k
Ud
or
n
W
SN VS
V
EM
CV
Chr 13
* * 
0
10
20
30
40
50
M
oc
k
Ud
or
n
W
SN VS
V
EM
CV
Chr 16 (574) * * 
0
40
80
120
160
M
oc
k
Ud
or
n
W
SN VS
V
Chr 16
 (109)
HeLaE
R
el
at
iv
e 
A
b
un
d
an
ce
* 
* 
*
* 
0
20
40
60
80
100
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
IFNB1
*
*
0
20
40
60
80
100
120
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
Chr 1 
(213)
* 
* 
* * 
0
5
10
15
20
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
Chr 2 *
0
10
20
30
40
50
60
70
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
Chr 5
* 
* 
* * 0
100
200
300
400
500
600
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
Chr 7
*
*
*
*0
50
100
150
200
250
300
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
Chr 9
* *
*
*
*
0
50
100
150
200
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
Chr 10
* 
* 
* 
* 
0
100
200
300
400
500
600
700
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
Chr 12
* 
* 
* * 0
200
400
600
800
1000
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
Chr 13
*
*
*
0
100
200
300
400
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
Chr 16 (574)
* 
* 
* 
* 
0
50
100
150
200
250
300
350
M
oc
k
Ud
or
n
W
SNSe
V
VS
V
EM
CV
EM
CV
Chr 16 (109)
A B
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
IF
N
B
1
1 
(2
13
) 2 5 7 9 10 12 13
16
 (5
74
)
16
 (1
09
)
EM
CV
Figure 8. Sites of Virus-Induced Transcription Factor Recruitment Result in Innate Antiviral RNA Transcription
(A and B) Namalwa cells were infected with (A) Sendai virus, (B) EMCV, or influenza A/Udorn/72 ormock-infected for 10 hr and analyzed by ChIP (IRF3, p65/RELA,
and MED1). Numbers on the x axis refer to the nviRNA locus chromosome number, with numbers in parentheses to distinguish loci that are located on the same
chromosome. Error bars denote standard deviation for triplicate PCR reactions.
(C–E) nviRNA induction by Sendai virus, influenza A/Udorn/72 or A/WSN/33, VSV, and EMCV infection. (C and D) Namalwa and (E) HeLa cells weremock-infected
or infected (5 pfu/cell), 5 3 106 cells were harvested 10 hr p.i. for RNA isolation, and RT-PCR was performed with primers for the indicated nviRNA locus and
GAPDH for normalization. Error bars denote standard deviation for triplicate PCR reactions. The asterisk denotes p% 0.05 and double asterisks denote that RNA
was not detected in mock-infected cells.
See also Table S7.IRF3 is able to organize promoter-specific recruitment of Pol II,
whereas NFkB provides the ability to stimulate its efficient and
processive elongation through its recruitment of P-TEFb
(Barboric et al., 2001; Brasier, 2008; Nowak et al., 2008; Har-
greaves et al., 2009). Gene-specific effects are certain to regu-
late the degree and quality of cooperation in this system, and
this phenomenon has been documented for several NFkB target
genes. Specific sequences within kB elements have been iden-
tified that can determine whether or not IRF3 is used as an
essential coactivator for NFkB-dependent activation (Leung
et al., 2004), and the p65/RELA component of NFkBwas demon-970 Cell Reports 4, 959–973, September 12, 2013 ª2013 The Authorstrated to be required as a coactivator of IRF3 target genes in
response to toll-like receptor 4 activation (Wietek et al., 2003).
The strong enrichment of IRF3 and NFkB targets in association
with MED1 suggests that theMediator complex is a likely vehicle
for coordinate organization of Pol II activation by these two reg-
ulators. In addition, the identification of E-box, CRE, and ETS
sequence elements among activated IRF3 targets suggests
additional coactivators in antiviral responses.
The prevalence of paused Pol II at genes involved in immuno-
logical signaling, environmental stress, and developmental pro-
cesses has several implications for the transcriptional regulations
of the human innate immune response (Muse et al., 2007; Adel-
man et al., 2009). Unlike the coordinated sequences of molecular
events that are required for Pol II recruitment at genes like Ifnb1,
preassociation of Pol II at an antiviral gene promoter can enable
efficient and rapid control of gene expression with virus-
activated transcription factor(s). Bypassing the need for more
complex regulatory steps is likely to enable immediate changes
in transcriptional responses to virus infection. Pol II pause
release can provide a means to fine-tune the expression of key
targets that are integral to the cellular response to infection by
regulating the intensity of inducible transcription beyond the
‘‘all or nothing’’ effects characteristic of de novo Pol II recruit-
ment. More complex mechanisms that remodel chromatin and
recruit Pol II de novo may represent a more secure system that
prevents inappropriate activation of signaling pathways and
biological responses in the absence of suitably strong stimula-
tion. Consequently, this may grant antiviral transcription factors,
like IRF3 and p65/RELA, the opportunity to work together with
transcriptional regulatory partners, such as Mediator and
NELF, to allow for collaborative regulation of a wider range of
antiviral transcription responses.
Annotated messenger RNA (mRNA)-coding and noncoding
genes account for only a small fraction of the genomic loci with
virus-inducible transcription factor and Pol II association. Unex-
pectedly, most virus-activated factor deposition and activation
of Pol II-mediated transcription was found to occur at regions
distal from known targets, many of which remain without anno-
tation in the human genome. These sites of antiviral transcription
feature virus-inducible occupation by IRF3 and/or p65/RELA as
well as Pol II and its transcriptionally active Ser2-phosphorylated
form. They encode RNA transcripts, termed nviRNAs, potentially
ranging from hundreds to thousands of bases throughout the
genome. Direct evaluation of transcription at a sample of these
loci confirms that they encode transcribed RNAs that respond
to virus infection (Figure 7E). Analysis of nviRNAs revealed their
common activation in diverse cell lines by several viruses tested,
including EMCV, Sendai virus, and influenza A virus. The poten-
tial roles for these RNAs during the antiviral response will be
revealed by further investigation, but as IRF3 and p65/RELA
play central roles in promoting their transcription, we speculate
that they participate in the regulation of the human innate
immune response by unique mechanisms. The number of
identified nviRNA loci suggests that a large portion of virus-
inducible transcription responses have been overlooked, and
these may represent new targets for use in diagnostic or thera-
peutic applications.EXPERIMENTAL PROCEDURES
Cell Culture and Virus Infection
The human immortalized Namalwa B cell line (American Type Culture Collec-
tion CRL-1432) was cultured in RPMI 1640 medium (Life Technologies), and
the cervical carcinoma line HeLa was cultured in Dulbecco’s modified Eagle’s
medium. Media were supplemented with 10% cosmic calf serum (Hyclone),
glutamine, 1 mM sodium pyruvate (Cellgro), and 1% penicillin/streptomycin
(Life Technologies). Infection of cells with Sendai virus (Cantell), influenza A
virus (A/Udorn/72 and A/WSN/33), VSV (Indiana), or EMCV (Mengo) was per-
formed at five plaque-forming units per cell (pfu/cell) in serum-freemedia. After
1 hr, cells were lightly centrifuged, washed, and resuspended in growth mediaCelsupplemented with 2% cosmic calf serum (Hyclone). For mock infection, cells
were subjected to all manipulations, with PBS substituted for virus inoculum.
Cells were centrifuged at 4C at indicated time points.
Expression Analysis
For mRNA analysis by RT-PCR, total RNA was extracted from 5 3 106 cells
using TRIzol Reagent (Invitrogen). Samples were treated with DNase I (Life
Technologies), and 1 mg of RNA was random primed and subjected to reverse
transcription with Superscript III (Life Technologies) for complementary DNA
synthesis. Quantitative real-time PCR (qPCR) was carried out using the
MX3000P SYBR Green real-time PCR system (Agilent) and analyzed using
the DDCT method. Expression was normalized against glyceraldehyde
3-phosphate dehydrogenase (GAPDH) and displayed as arbitrary units. The
primers used for this analysis are listed in Table S7.
ChIP Assays
ChIP analysis was carried out as described in Lee et al. (2006).
ChIP-qPCR Analysis
ChIP DNA was analyzed using SYBR Green real-time PCR analysis (Agilent).
ChIP signal was normalized to total input. The oligos used for this analysis
can be found in Table S7.
SOLiD ChIP-Seq Data Analysis
Data analysis was performed using HOMER, a software suite for ChIP-seq
analysis. Each ChIP-seq experiment was normalized to a total of 107 uniquely
mapped tags by adjusting the number of tags at each position in the genome
to the correct fractional amount given the total tags mapped. This normaliza-
tion was used for all downstream analysis (see Extended Experimental
Procedures).
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